ArticleAdvances in therapy2024

The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast.

Peter C Black et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.